TGFB1 and neoplasm: For example, in vitro and in vivo experiments using patient-derived cells showed that CAF-secreted TGFB acted synergistically with tumor cell-expressed HIF-1α to sustain 5-FU/oxaliplatin resistance via activation of the hedgehog pathway [42].